NHMRC Clinical Trial Centre | Improving Health Outcomes

Search results

4893 items matching your search terms.

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 20,536 high-risk individuals: randomised placebo-controlled trial

Keech, AC on behalf of the Heart Protection Study Investigators Group,

Significant lipid changes with fenofibrate in type 2 diabetes in a large-scale trial to prevent cardiovascular disease

Keech, AC; Best, J; Barter, P; Scott, R; Simes, RJ; Taskinen, M-R

The importance of PPAR alpha agonists in the treatment of metabolic syndrome and type II diabetes

Keech, AC; Best, J; Barter, P; Scott, R; Simes, RJ; Taskinen, M-R

Significant lipid changes in a large-scale trial of fenofibrate to prevent cardiovascular disease in type 2 diabetes. The FIELD Study Investigators

Keech, AC; Best, JD; Scott, RS; Barter, PJ; Simes, RJ; Forder, P; Taskinen, M-R

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 20,536 high-risk individuals: randomised placebo-controlled trial and implications for guidelines

Keech, A.C.

Balancing the outcomes: Reporting adverse events

Keech, A. C. Wonders, S. M. Cook, D. I. Gebski, V. J.

Neither clopidogrel pre-treatment nor heparin-coated stents reduces peri-procedural troponin I elevation

Lefkovits, J Eccleston, D Warren, R Clark, D Chan, R Ajani, I Keech, A

Low-grade inflammation, endothelial activation, and carotid intima-media thickness in type 2 diabetes

Leinonen, E Hiukka, A Hurt-Camejo, E Wiklund, O Sarna, S Mattson Hultén, L Westerbacka, J Salonen, R Salonen, T Taskinen, M-R

Regional differences in 30-day mortality of acute myocardial infarction

Li, L Hudson, HM

Decision models for valuing effectiveness of new diagnostic technologies

Liu, Z Hudson, HM Lord, S Gebski, V

Multiple analyses in clinical trials: sound science or data dredging?

Lord, SJ Gebski, VJ Keech, AC

Synthesizing evidence about emerging diagnostic technologies for practice and policy: mind the gap!

Lord, S Ghersi, D Marinovich, L

Synthesizing evidence about emerging diagnostic technologies for practice and policy—mind the gap!